Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taipei Exchange - Delayed Quote TWD

Shine-On BioMedical Co.,Ltd. (6926.TWO)

Compare
63.50
-1.40
(-2.16%)
At close: 12:41:06 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Hongzhe Jiang General Manager -- -- --

Shine-On BioMedical Co.,Ltd.

No. 633, Taiwan Blvd.
5F-6 Section 2 Xitun District
Taichung, 407569
Taiwan
886 4 2327 2888 https://www.shineon-bio.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
22

Description

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2021 and is based in Taichung, Taiwan.

Corporate Governance

Shine-On BioMedical Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers